Highlights d NR4A nuclear orphan receptors possess a poly-ADP-ribose (PAR)-binding pocket d PAR binding is essential to NR4A activity in DNA repair d Ionizing radiation induces PARylation of DNA-PKcs kinase d NR4As promote DNA-PKcs autophosphorylation in a PARdependent fashion Correspondence mzm23@mrc-tox.cam.ac.uk In Brief DNA damage induces poly-ADPribosylation (PARylation) of repair factors recruited to DNA lesions. Munnur et al. identify a zinc-finger-type poly-ADPribose-binding domain in NR4A nuclear orphan receptors that targets PARylated DNA-PKcs repair kinase, facilitating its autophosphorylation and repair of double-strand DNA breaks.
INTRODUCTION
Nuclear DNA is under a constant threat of damage by reactive oxygen species, aberrant activity of enzymes and/or exogenous radiation. Therefore, efficient DNA repair is essential for survival of all organisms (Jackson and Bartek, 2009) . Although doublestrand breaks (DSBs) can be repaired by several pathways, classical non-homologous end joining (c-NHEJ) is responsible for the bulk of DSB repair (Waters et al., 2014) . NHEJ is initiated by sequence-independent binding of Ku70/Ku80 dimers to exposed DNA ends at DSBs. DNA-bound Ku rapidly recruits DNA-PKcs kinase, resulting in its activation and DNA-PKcs auto-phosphorylation. Some DSBs undergo processing by Artemis nuclease before ligation of DNA ends catalyzed by the XRCC4/ LigaseIV complex (Chiruvella et al., 2013) . Posttranslational protein modifications have important regulatory function in DSB repair (Polo and Jackson, 2011) . For example, protein poly-ADP-ribosylation (PARylation) catalyzed by poly-ADP-ribose polymerases (PARPs) (Crawford et al., 2018; Luo and Kraus, 2012) has been implicated in c-NHEJ (Luijsterburg et al., 2016) and can stabilize protein-protein interactions because of function of specialized poly-ADP-ribose (PAR)-binding domains (Ahel et al., 2008) . The NR4A family of nuclear orphan receptors consists of three members in mammals (NR4A1-NR4A3) and one member in Drosophila (DHR38). NR4As are sequence-specific DNA-binding transcription factors that regulate essential cellular processes such as cell growth, metabolism, and differentiation (Safe et al., 2016) . NR4As possess a conserved DNAbinding domain (DBD) composed of two zinc fingers (Zn1 and Zn2). Typically, the Zn1 contacts DNA (Meinke and Sigler, 1999) , while Zn2 is not involved in direct DNA binding. A direct role for NR4As has been discovered in DNA DSB repair, but the mechanism remains elusive (Jagirdar et al., 2013; Malewicz et al., 2011; Ramirez-Herrick et al., 2011; Smith et al., 2008; Yin et al., 2017) . Here we show that NR4As' DBD is functionally unique, because it is able to bind both DNA and PAR. PAR binding occurs through the Zn2 region and targets poly-ADP-ribosylated DNA-PKcs to facilitate activity of the DNA-PK repair complex during c-NHEJ. Altogether, we define a function of NR4As in DSB repair and propose a way for pharmacological targeting of NR4A in cancer therapy.
RESULTS

Conserved Zn2 of NR4A2 Encodes a PAR-Binding Domain
Given that NR4A recruitment to DNA damage sites depends on PAR ( Figure 1A ) (Jagirdar et al., 2013; Malewicz et al., 2011) , we asked whether NR4As could bind PAR directly. Recombinant NR4A2 protein strongly bound PAR ( Figure 1B ; Figures S1A-S1D). The ability to bind PAR resides in the second zinc finger (Zn2) of the NR4A2 DBD ( Figures 1B and 1C) . Although the isolated Zn2 region bound PAR weakly ( Figure 1B , middle panel), addition of either Zn1 or C-terminal extension (CTE) restored PAR binding, suggesting that either Zn2 alone does not fold properly or Zn1 and CTE might contribute allosterically to Zn2 function ( Figure 1B , lower panel). PAR-binding ability extends to all NR4A family members, including the Drosophila NR4A homolog DHR38 ( Figure 1D ). PAR and NR4A interaction is physiologically relevant, because it is comparable to that of the LigaseIV BRCT domain ( Figure 1E ), which binds PAR with nanomolar affinity (Li et al., 2013) .
DNA Binding and PAR Binding by NR4A2 Can Be Separated Biochemically
In the crystal structure of NR4A1 bound to DNA oligonucleotide (Meinke and Sigler, 1999) , the Zn2 region is protruding away from DNA and does not contact DNA ( Figure 2A ). We thus assumed that separation of function between DNA binding and PAR binding would be possible. PAR recognition typically occurs via basic and aromatic amino acid residues (Ahel et al., 2008) . We have generated various point mutants in fulllength NR4A2 and assayed for PAR binding ( Figure 2B ; Figure S2A ). Several mutants with reduced affinity for PAR were found. Combining these mutations in a quadruple mutant (KRRY) showed almost complete absence of PAR binding. None of these mutants showed any effect on sequence-specific DNA binding ( Figure 2C ). In contrast, arginine residue 319 (R319), conserved across the whole NR family ( Figure S1E ), contacts DNA (Meinke and Sigler, 1999) , and R319A mutation abolished DNA binding ( Figure 2C ; Figure S2B ) without affecting PAR binding ( Figure 2B ). All mutants (except R319A) prominently induced NR4A-specific reporter genes ( Figure 2D ) and showed normal nuclear localization ( Figure 2E ). To exclude a possibility that our synthetic reporter experiments failed to account for promoter-or enhancer-specific effects we identified the cellular gene C8ORF4/TC-1 inducible by wildtype (WT) NR4A2 (but not R319A mutant) ( Figure 2F ; Table  S1 ). NR4A2 K303A also induced expression of C8ORF4/TC-1 ( Figure 2F ). K303A mutation showed consistent activity across multiple assays; therefore, it was selected as the prototypical separation-of-function mutant for further functional experiments. Furthermore, K303A strongly attenuated recruitment of NR4A2 to laser-induced DNA damage in vivo ( Figure 2G ). We also found that mutations of the first (CEAA), the second (C305A), or both (CC/AA) zinc-finger domains affected DNA binding, reporter-based transcription and PAR binding (Figures S2D-S2F) while maintaining normal nuclear localization (Figure S2C) . Cysteine mutation of Zn1 (CEAA) also affected PAR binding ( Figure S2F ), consistent with our prior observation that Zn1 facilitates Zn2 folding or contributes allosterically to Zn2 activity ( Figure 1B , middle and lower panels). We conclude that zinc-finger cysteine mutants of NR4A produce a broad effect on DBD functionality.
Zn2 of NR4A Harbors a Distinct PAR-Binding Pocket
Localization of the PAR-binding domain to the Zn2 of NR4A suggested the presence of a cleft accommodating PAR. Molecular modeling revealed the presence of a distinct pocket in the Zn2 domain of NR4A1 ( Figure 2H ). Zn2s from the related NR5A class of receptors do not possess a similar pocket ( Figure 2H ), consistent with a divergent protein sequence ( Figure 1F ). Systematic mutagenesis of amino acids forming the NR4A2 Zn2 pocket revealed that most of these mutants reduced PAR-binding capacity ( Figure 2I ) without affecting DNA binding ( Figure 2K ) and maintained nuclear localization ( Figure 2J ). Comparison of NR4A PAR-binding pocket to ribofuranosyladenosine (RFA)bound APLF revealed that the binding surface of NR4A1 also has a wide cleft-like fold, which could accommodate PAR chains similar to APLF ( Figure S2G ). In summary, molecular modeling and empirical data identified a distinct PAR-binding pocket in the Zn2 domain of NR4A, which could potentially be targeted with NR4A-specific small molecules.
NR4A1 and NR4A2 Redundantly Function in the c-NHEJ DSB Repair Pathway
Given that U2OS cells express NR4A1 and NR4A2 (Malewicz et al., 2011) , we derived NR4A1 (cA1), NR4A2 (cA2), or combined NR4A1/2 (cA1/A2) knockout lines by CRISPR ( Figures S3A-S3C ). NR4A1/2 double-knockout cells had a defect in DSB resolution ( Figure 3A ) and showed substantial radiosensitivity (Figure 3C) , while single knockouts repaired DNA efficiently. cA1/ A2 cells synchronized in G1 also showed delayed DSB repair ( Figure 3B ), suggesting an impairment of c-NHEJ repair pathway. cA1/A2 cells had slightly elevated basal level of DSBs ( Figures 3A and 3B ). Foci counting experiments were corroborated with neutral COMET assays, revealing a DSB resolution defect in NR4A-depleted cells ( Figure S3D ). NHEJ is initiated by Ku70/Ku80 dimer binding to free DNA ends at DSBs (Gottlieb and Jackson, 1993) . NR4A double-knockout cells showed a substantial defect in Ku70 mobilization to DNA damage sites ( Figure 3D ). The current model of NHEJ activation places DNA-PKcs recruitment and autophosphorylation downstream of Ku loading (Meek et al., 2008) . Depletion of Ku80 protein by small interfering RNA (siRNA) led to a dramatic reduction of autophosphorylated DNA-PKcs (phDNA-PKcs) on chromatin ( Figure 3E ) without affecting the levels of nuclear soluble phDNA-PKcs. cA1/A2 cells also showed strongly decreased levels of phosphoDNA-PKcs on chromatin at early time points after irradiation, although the effect was less dramatic in comparison to Ku80-depleted cells ( Figure 3F ; Figure S3E ). Phosphorylation of DNA-PKcs in the nuclear soluble compartment was unaffected by NR4A1/2 deficiency. We conclude that NR4A1 and NR4A2 are redundant in facilitating DNA repair via c-NHEJ and control the levels of phDNA-PKcs on chromatin. Autophosphorylated DNA-PKcs is critically important for activation of Artemis nuclease in c-NHEJ (Goodarzi et al., 2006) . Thus, we assessed the activity of Artemis in both control and cA1/A2 cells. As reported previously (Riballo et al., 2004) , siRNA-mediated depletion of Artemis delayed repair of a subset of DSBs ( Figure 3G ; Figure S3G ). Combined NR4A1/2 and Artemis deficiency resulted in an additive effect on DSB repair, demonstrating that Artemis activity was not compromised by NR4A1/ 2 deletion ( Figure 3G ). NR4A loss was epistatic with PARP-1 depletion ( Figure 3H ; Figure S3H ). In contrast to NHEJ defect, homologous recombination (HR)-associated RAD51 foci efficiently formed and resolved in cA1/A2 cells ( Figure 3I ). Observed DSB repair defect in cA1/A2 cells was confirmed by HR-and NHEJ-specific reporter cassette assays ( Figure S3F) . To address the role of PAR binding by NR4A2 in DSB repair, we have re-expressed NR4A2 protein in cA1/A2 cells using the retroviral expression system ( Figure S4A ). Endogenous NR4A2 protein is expressed in U2OS cells as full-length receptor migrating at 66 kDa and a faster-migrating 60 kDa Tinur isoform (Okabe et al., 1995) , which lacks 62 N-terminal residues (Figure 1C ; Figures S3A and S4A ). The Tinur isoform showed slightly diminished transcriptional activity in comparison to the fulllength receptor ( Figure S4B ) even as it efficiently translocated to laser-induced DNA damage sites ( Figure S4C ). Unlike fulllength WT NR4A2, Tinur failed to reverse the DSB repair defect in NR4A1/2 knockout cells ( Figure 4A ). NR4A2 K303A mutant also failed to rescue the DSB repair defect in cA1/A2 cells (Figure 4A ; Figure S4D ), although it showed a residual effect on DNA-PKcs autophosphorylation on chromatin and Ku70 recruitment to DNA lesions in cA1/A2 cells ( Figures 4B and 4C ). Furthermore, blocking cellular PARylation resulted in somewhat diminished Ku70 recruitment to DSBs ( Figure S4E ), consistent with earlier reports (Luijsterburg et al., 2016) . In summary, fulllength NR4A2 acts in c-NHEJ in a Zn2-dependent fashion. We hypothesized that either DNA-PKcs or Ku complex might be the target of the NR4A2 Zn2 domain given that these proteins (but no other core NHEJ factors) had been reported to undergo PARylation in vivo (Martello et al., 2016) and both can interact with NR4A receptors (Malewicz et al., 2011; Zhao et al., 2011) . We therefore purified DNA-PKcs protein and Ku70/Ku80 dimer to homogeneity and assessed their PARylation status (Figures 4D and 4E) . Consistent with very high basal level of cellular PARylation ( Figure S4F ), we found PARylated DNA-PKcs and Ku in untreated cells (Figures 4D and 4E) . Only PARylation levels of DNA-PKcs protein were elevated by ionizing radiation (IR) treatment ( Figures 4D and 4E ). Next, we compared the ability of DNA-PKcs/Ku proteins purified from IR-treated cells (maximal PARylation) against proteins purified from cells treated with IR and PARP inhibitor (no PARylation) to bind to the DBD of NR4A2. Although both DNA-PKcs and Ku bound the NR4A2 DBD, only DNA-PKcs showed PAR-dependent binding (Figure 4G) . We next wondered of whether the diminished Ku70 recruitment observed in cA1/A2 cells was an indirect result of a defect in DNA-PKcs functionality. In striking similarity to cA1/ A2 cells, depletion of DNA-PKcs protein in U2OS ( Figure S4G ) phenocopied the effect on Ku70 recruitment ( Figure 4H) . Thus, the assembly of the NHEJ complex in human cells is cooperative in the sense that the initial Ku binding leads to recruitment of DNA-PKcs, which in turn stabilizes Ku at DSBs. Ku stabilization is aided by PAR-dependent docking of NR4A2 to DNA-PKcs.
DISCUSSION
NR4As had primarily been recognized as sequence-specific DNA-binding transcriptional regulators (Safe et al., 2016) . We and others proposed a direct role for NR4As in DNA DSB repair, which is a DNA sequence-independent process (Malewicz and Perlmann, 2014) . In this manuscript, we present a model of how these contrasting activities of NR4As are executed. We find that DBD of NR4A is bi-functional and can bind DNA to regulate transcription (in a sequence-specific fashion) or PAR to facilitate DSB repair. Given that NR4A2 overexpression can accelerate DSB repair (Malewicz et al., 2011; Yin et al., 2017) , it appears that the DNA-PK assembly is a rate-limiting step in this process. Thus, physiological and pathological conditions in which the expression of NR4A is altered, such as stress responses and various cancers, might be associated with variable NHEJ activity, with important consequences for cell physiology and drug responses. Loss of NR4A expression in acute myeloid leukemia (AML) is common and correlates with defective DSB repair (Ramirez-Herrick et al., 2011) . In model organism Dictyostelium, the Ku70 homolog bears a PAR-binding domain, which is essential for effective c-NHEJ (Couto et al., 2011) . Our data suggest that in mammalian cells, NR4As perform this accessory (G) DSB levels measured as 53BP1 foci count per nucleus after 24 h post-1 Gy irradiation in control versus NR4A1/2 knockouts (cA1/A2) 72 h after transfection with reference siRNA (siCtrl) or Artemis-specific siRNA (siArtemis) (n = 3; error bars represent SEM). Asterisks denote statistically significant differences in relation to the control (siCtrl) sample (p < 0.05). (H) DSB levels measured as 53BP1 foci count per nucleus after 24 h post-1 Gy irradiation in control versus NR4A1/2 knockouts (cA1/A2) 72 h after transfection with reference siRNA (siCtrl) or PARP1-specific siRNA (siPARP1) (n = 3; error bars represent SEM). Asterisks denote statistically significant differences in relation to the control (siCtrl) sample (p < 0.05). (I) RAD51 foci count per nucleus at indicated times after 5 Gy irradiation in control versus NR4A1/2 knockouts (cA1/A2) (n = 3; error bars represent SD). function. Many cancer therapies function by inducing persistent DNA damage (O'Connor, 2015) . Inhibition of central NHEJ enzymes (DNA-PKcs and LigaseIV) was previously tested in the clinic, although these efforts were unsuccessful due to the toxicity of used compounds (Hosoya and Miyagawa, 2014) . NR4As have long been perceived as attractive targets for drug discovery (Mohan et al., 2012) . However, efforts to identify small molecules specific to NR4As were hampered by the lack of a suitable targeting strategy because of poor druggability of NR4A proteins (Wang et al., 2003) . Our identification of a distinct PAR-binding pocket in Zn2 of NR4A, which operates in DSB repair, opens a way for development of NR4A2-specific small molecules for selective inhibition of NR4A2 PAR binding. These in principle could be of substantial value in cancer therapy, particularly on tumors characterized by prominent expression of NR4As, such as breast cancer ( , 2013) . We acknowledge that substantial work is necessary to realize this potential and to show benefit over currently used broad PARP inhibitors such as olaparib.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture U2OS human osteosarcoma cell line was obtained from ATCC and cultured in DMEM medium (high glucose) supplemented with 10% FCS. 293H cells were purchased from Invitrogen and cultured in DMEM medium (high glucose plus pyruvate) supplemented with 10% FCS. For G1 cell cycle synchronization standard double thymidine block protocol had been used.
METHOD DETAILS
Western blotting
Cell extracts (WCE/whole cell extracts or nuclear extracts) were mixed with 4x Laemmli sample buffer (Bio-Rad; cat. 1610747) and boiled for 5min. Samples were then resolved on pre-cast TGX gradient 4%-15% gels (Bio-Rad). Gels were transferred to nitrocellulose membranes via Trans-Blot Turbo system (Bio-Rad) according to manufacturer's instructions. After transfer, the membranes were blocked in BLOTTO TBS-T blocking solutions for at least 30min at room temperature. Primary antibodies were applied in 5% BSA TBS-T solution for overnight 4 C incubations. Secondary antibodies (HRP-coupled stabilized IgG from Pierce) were applied in TBS-T solution for 1hr at room temperature. Western blots were subsequently developed with Clarity HRP substrate (Bio-Rad) and exposed to Hyperfilm ECL films (GE Healthcare).
Plasmids/Cloning
GST fusion vectors were constructed by inserting PCR amplified full length NR4A1, NR4A2, NR4A3, DHR38, NTD/DBD/LBD/Zn1/ Zn2/CTE of NR4A2 and DBD of NR4A1 coding fragments or hLigaseIV BRCT domain (aa 600-911) into pGEX-6P-1 vector (GE Healthcare) using the Quick ligation kit (NEB Inc). The PCR amplified inserts were prepared using the Q5 High-Fidelity DNA polymerase (NEB Inc). The inserts were cloned into the pGEX-6P-1 vector at the BamHI (or BglII) and XhoI cloning sites. Cloning was verified by diagnostic digestion using restriction enzymes followed by DNA sequencing (PNACL -University of Leicester, Leicester, UK). pCMX mammalian expression vectors encoding full-length NR4A1, NR4A2, NR4A3 and DHR38 were previously described (Malewicz et al., 2011) . For the generation of mCherry-NR4A2 fusions PCR amplified full-length mouse NR4A2 were subcloned in mCherry-LacI plasmid (gift from Dr Tom Misteli, NIH, USA). For generation of EGFP-NR4A2 fusions PCR amplified full-length mouse NR4A2 was cloned in-frame into pEGFP-N1 plasmid (Clontech).
Generation of recombinant retroviruses
VSV-pseudotyped retroviruses were generated with Clontech Pantropic Retroviral Expression System (Cat. No. 631512) based on pBabe-puro (Addgene) vector and according to manufacturer's instructions. Recombinant retroviruses carrying empty vector, F-L NR4A2 WT, Tinur or F-L NR4A2 K303 cDNAs were generated according to manufacturer's instructions. In brief GP2-293 packaging cell line (Clontech/TaKaRa) was transiently transfected with a mixture of plasmids containing pBabe-puro vector and coat expression plasmid (VSV). After 72hr of incubation conditioned medium was harvested, filtered through 0,45 mm syringe top filter and applied to target cells in the presence of polybrene (SantaCruz). After 24hr of incubation stably transduced cells were selected out by puromycin selection (2 mg/ml; Invitrogen).
SiRNA-mediated mRNA knockdown Control (reference), Ku80-, Artemis-, PARP1-, DNA-PKcs-specific siRNA were purchased from SantaCruz Biotechnology and transfected to U2OS by Lipofectamine RNAiMAX (Life Technologies) at 50nmol concentration. Cells were analyzed at 48-72hr post transfection. 
Site directed mutagenesis
The site directed mutagenesis was performed using PfuUltra High Fidelity DNA polymerase (Agilent Technologies). The reaction mixture contained 0.2mM dNTPs, 50ng template plasmid, 2.5U Pfu DNA polymerase and 125ng of each primer. PCR amplification reaction required 18 cycles of step 1: 98 C for 30sec, step 2: 95 C for 30sec, step 3: 55 C for 1min, step 4: 68 C for 5mins. PCR product was subjected to 2 cycles of incubation with 20U DpnI (NEB Inc) enzyme at 37 C for 1h, then transformed into NEB 5-alpha E.coli strain (NEB Inc). Recovered plasmids were sequenced via in-house sequencing facility (PNACL -University of Leicester, Leicester, UK) to identify desired mutations.
Recombinant protein expression and purification 1-10ng/ml of pGEX-6P-1 plasmid containing desired cDNA for expression (GE Healthcare) was transformed in 10 mL aliquot of Rosetta 2 competent cells (Novagen). Transformed cells were spread onto ampicillin agar plate and incubated overnight at 37 C. Individual colony was picked into a 100mL LB starter culture containing 100 mg/mL ampicillin and 34 mg/mL chloramphenicol and incubated overnight at 37 C. The starter culture was further expanded into 500mL culture containing ampicillin and chloramphenicol and incubated for 6h at 37 C. The culture was then induced with 0.1mM IPTG and allowed to express the recombinant protein overnight at 18 C. Following induction, the culture was supplemented with 50 mM ZnCl 2 . Cells were harvested by centrifugation at 6000 g for 15mins at 4 C. The cells were suspended in 20mL GST lysis buffer (50mM Tris pH 7.5, 150mM NaCl, 1% Triton X-100, 0.1% b-mercaptoethanol, 0.4mM PMSF, 1X EDTA free Complete Protease Inhibitor cocktail (Roche) and 1mM benzamidine) and lysed by sonication. The lysate was then centrifuged at 20000 g for 30mins at 4 C. The cleared cell lysate supernatant was incubated with 200 mL pre-washed gluthathione Sepharose 4B (GE Healthcare) for 1h at room temperature. The protein bound beads were washed thoroughly with GST-wash buffer (50mM Tris pH 7.5, 500mM NaCl, 1% Triton X-100, 0.1% b-mercaptoethanol, 0.4mM PMSF, 0.5X EDTA free Complete Protease Inhibitor cocktail (Roche) and 1mM benzamidine). The beads were equilibrated with cleavage buffer (50mM Tris pH 7.0, 150mM NaCl and 1mM DTT). To obtain GST-tag cleaved recombinant proteins the beads were incubated with 100 mL cleavage buffer supplemented with 15U PreScission Protease (GE Healthcare) overnight at 4 C. Protein concentration was measured using NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Scientific). For experiments shown in Figure 2B NR4A2 full-length protein preparations were further purified by gel filtration on Ä ktamicro system (GE Healthcare) using Superdex 200 Increase 3.2/300 gel filtration column according to manufacturer's protocol. The proteins were further electrophoresed on precast 4%-15% Mini-PROTEAN TGX gels (Bio-Rad) and stained with quick Coomassie stain (InstantBlue; manufactured by Expedeon) to assess quality.
Neutral COMET assays
To induce double strand DNA breaks (DSBs) cells were treated with 100 mg/ml of zeocin (bleomycin derivative; Invitrogen) for 30min. Thereafter cells were either washed with medium to remove the zeocin and allow DNA repair to continue for 90min or harvested directly for COMETs. 100x10 3 cells were mixed with 100 mL of LMP agarose in PBS (In-Cert, LONZA) and spread on a frosted microscope slide (precoated with standard 1% agarose; LONZA) and covered with 64mm coverslip. Agarose was allowed to solidify for 15min in the fridge. Subsequently coverslip was removed and the microspore slide with cells embedded in agarose was incubated in neutral lysis solution (2% sarkosyl, 0.5M EDTA, 0.5mg/ml proteinase K, pH 8.0) overnight in the fridge followed by 1hr at 37 C. Slides were then submerged in 1xTBE buffer for 30min in the cold room and subsequently electrophoresed at 15V for 15mins in 1xTBE buffer. Slides were recovered from the electrophoresis chamber and placed in DNA precipitation solution (1M ammonium acetate in 99% ethanol) for 30min at room temperature. Slides were then washed with 70% ethanol for 10min at room temperature, airdried and stained with SYBRGOLD stain. Subsequently slides were mounted with Vectashield HardSet mounting medium (Vector Labs). COMETs images were acquired on a fluorescent microscope and quantified as percentage (%) of DNA in tail with CometScore (TriTec Corp., USA). At least 30 COMETs were scored per sample.
Purification of FLAG-DNA-PKcs and FLAG-Ku70/Ku80 proteins from mammalian cells FLAG-tagged proteins were purified from suspension grown 293 cells (for FLAG-DNA-PKcs a stable clone was used; for FLAG-Ku70/ Ku80 complex cells were transiently transfected with pCMX-FLAG-Ku70 and pCMX-FLAG-Ku80 expression vectors). Cells were washed twice in ice-cold PBS-MC (PBS, 1 mM MgCl 2 , 1 mM CaCl 2 ) and gently resuspended in 4.5 ml ice-cold Hypotonic Buffer (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA supplemented with Complete protease inhibitors (Roche Diagnostics), 10 mM NaF, 1 mM Na3VO4, 10 mM MG132, 1 mM DTT, 1 mM PMSF). After incubation for 15 min, Igepal CA630 was added to 0.05% final concentration and cells were vortexed for 10 s and centrifuged at 2300 3 g for 5 min. Crude nuclei were washed with 1 ml Hypotonic Buffer and re-centrifuged as above. Pellets mixed by end-to-end rotation with 15 ml high salt buffer (20 mM HEPES, pH 7.9, 500 mM NaCl, 0.5 mM MgCl 2 , 20% glycerol) supplemented as described above for 30 min on ice. Following centrifugation at 15000 3 g for 30 min, nuclear extracts were incubated with M2 beads (SigmaAldrich) for 1-2hr on ice, beads were subsequently washed 3x10ml of 1M NaCl containing buffer to remove any associated proteins. Pure proteins eluted with elution buffer containing 0.2 mg/ml 3X FLAG peptide (SigmaAldrich).
